MYUNGMOON Pharm co.,Ltd (KRX:017180)
South Korea
· Delayed Price · Currency is KRW 1,687.00
-93.00 (-5.22%)
Mar 9, 2026, 3:30 PM KST
MYUNGMOON Pharm co.,Ltd Revenue
MYUNGMOON Pharm co.,Ltd had revenue of 49.86B KRW in the quarter ending September 30, 2025, with 6.13% growth. This brings the company's revenue in the last twelve months to 193.64B, up 7.49% year-over-year. In the year 2024, MYUNGMOON Pharm co.,Ltd had annual revenue of 186.44B with 9.95% growth.
Revenue (ttm)
193.64B
Revenue Growth
+7.49%
P/S Ratio
0.29
Revenue / Employee
665.44M
Employees
291
Market Cap
56.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 186.44B | 16.88B | 9.95% |
| Dec 31, 2023 | 169.57B | 17.43B | 11.46% |
| Dec 31, 2022 | 152.13B | 14.38B | 10.43% |
| Dec 31, 2021 | 137.76B | 9.91B | 7.75% |
| Dec 31, 2020 | 127.85B | -21.49B | -14.39% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aprogen Biologics | 74.91B |
| Yuyu Pharma | 139.51B |
| Enzychem Lifesciences | 72.17B |
| Kukje Pharma | 173.80B |
| CKD Bio | 159.93B |
| Ildong Holdings | 620.44B |
| Kyongbo Pharmaceutical | 252.20B |
| Jeil Pharma Holdings | 707.15B |